2023年食管癌临床治疗进展  

An annual review of advance in esophageal cancer in 2023

作　　者：焦曦 戴婷婷 鲁智豪[1] Jiao Xi;Dai Tingting;Lu Zhihao(Department of Gastrointestinal Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China)

机构地区：[1]北京大学肿瘤医院暨北京市肿瘤防治研究所消化肿瘤内科,北京100142

出　　处：《肿瘤综合治疗电子杂志》2024年第2期1-13,共13页Journal of Multidisciplinary Cancer Management(Electronic Version)

基　　金：国家自然科学基金面上项目(82073230)。

摘　　要：2023年食管癌领域的研究百花齐放,多个研究将对食管癌的临床实践产生重要影响,本文将从围手术期治疗、放化疗研究、晚期食管癌药物治疗和免疫治疗耐药研究等角度出发,系统总结2023年度食管癌领域的重要临床研究,以推动食管癌的精准治疗。In 2023,the research in thefield of esophageal cancer isflourishing,and multiple studies will have an important impact on the clinical practice of esophageal cancer.This article will systematically summarize the important clinical research in thefield of esophageal cancer in 2023 from the perspectives of perioperative treatment,radiotherapy and chemotherapy research,advanced esophageal cancer drug treatment and immunotherapy resistance research,in order to promote the precise treatment of esophageal cancer.

关 键 词：食管癌 围手术期治疗 药物治疗 免疫治疗 

分 类 号：R735.1[医药卫生—肿瘤]